Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study
Abstract Cyclophosphamide (CPA) dosing by body surface area (BSA, m2) has been questioned as a predictor for individual drug exposure. This study investigated phosphoramide mustard-hemoglobin (PAM-Hb, pmol g−1 Hb) as a biomarker of CPA exposure in 135 female breast cancer patients receiving CPA duri...
Guardado en:
Autores principales: | S. A. M. Gernaat, H. von Stedingk, M. Hassan, H. P. Nilsson, K. A. Rodriguez-Wallberg, E. Hedayati, P. Rydberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4da5692c7f0b46adbbcf22da4b21fe1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safe decontamination of cytostatics from the nitrogen mustards family. Part one: cyclophosphamide and ifosfamide
por: Štenglová Netíková IR, et al.
Publicado: (2018) -
Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Ömer Faruk Bahçecioğlu, et al.
Publicado: (2021) -
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Julia Foldi, et al.
Publicado: (2021) -
Acute Effects of Sulphur Mustard Gas on the Number of Lymphocytes in the Rat's Spleen
por: Mehrdad,Jahanshahi, et al.
Publicado: (2008) -
Transplantation after Mustard operation for transposition of the great arteries
por: Shintaro Katahira, et al.
Publicado: (2021)